Latex allergy sublingual immunotherapy - ALK-Albello
Alternative Names: SLIT-Latex®Latest Information Update: 07 Jul 2016
At a glance
- Originator ALK-Abello
- Class Allergens; Allergy immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypersensitivity